Reach Us +1-947-333-4405
Challenges And Exciting Solutions To Downstream Bioprocessing Operations For The Manufacturing Of Therapeutic Vaccine Candidates | 9847
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Vaccines & Vaccination

Timothy Lee
ScientificTracks Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.016
T he cultivation and fermentation processing using fed-batch fermentation or perfusion is rather inexpensive in delivering high yields of target proteins. However, the downstream processing for the recovery and purification of the proteins can be challenging. This presentation summarizes the systematic methodology for the clarification of bacterial and viral vaccine proteins. The methodology pertains to the clarification of vaccine proteins that are extracellular (i.e. viral or bacterial product) or intracellular (i.e. bacterial soluble protein or inclusion body). The methodology was established based on data related to process economics, recovery and purity of the clarified material prior to downstream column purification. Based on the analysis, we have found that the initial step of clarification after fermentation should be centrifugation. This centrifugation step serves to separate the protein of interest from cells, if the product of interest is extracellular, or to concentrate the cells to an optical density for homogenization, if the product of interest is intracellular. In the case of an extracellular protein, a final ultrafiltration step is usually performed to concentrate and condition the product before column purification. In the case of proteins that are intracellularly expressed, the clarification of soluble protein is best recovered, after homogenization, using microfiltration followed by a final ultrafiltration step to concentrate and condition the protein prior to column chromatography. The clarification of inclusion body is best recovered and purified using centrifugation where the centrifugation helps facilitate better separation of the denser inclusion body particles from the lighter cellular debris. In addition, other methods such as a direct capture step (i.e. modified suspended bed chromatography) were economical in proteins as it reduced additional downstream columns due to its selectivity. Other membrane technologies (Q, HIC, His) are discussed in their ability to reduce column chromatography steps downstream for improve recovery, purity and cost.
Timothy Lee received his Ph.D. in Biochemical Engineering. The area of research was focused on the mechanical and catalytic stability of immobilized enzymes. He then did a post-doctoral fellowship at Sanofi pasteur, Canada, where he was involved in the optimization of primary recovery processes for bacterial systems, mainly focusing on micro-filtration, centrifugal and chromatographic separations. As a senior development scientist within sanofi pasteur, He has played a key role in the development of different bacterial media, fermentation and purification optimization and scale-up as well as the transfer of processes to Industrial operations for manufacturing and externally to CMOs. He has also published many patents and scientific papers and has presented extensively, globally, over the last several years, outlining the work performed in the industry. As a director of bulk manufacturing and operations, he was involved extensively in cGMP commercial manufacturing, facility qualification, process validation and continuous improvement initiatives for the global organization utilizing lean six sigma training for the biopharmaceutical industry. He is currently a Senior Scientific Consultant for Latham Biopharm Group specializing in CMC and winning of government contracts and continues to interact with vendors to find new technologies to improve and simplify the industrial operation for the manufacture of vaccines.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicals[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version